Karachi, Pakistan

Mohammad Iqbal Choudhary

This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Hej Research Institute Karachi University, Other. Active years: 2008-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammad Iqbal Choudhary. Retrieved from https://idiyas.com/inventor/mohammad-iqbal-choudhary

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 66.7

Average Co-Inventor Count = 5.6

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:

goldMedal1 out of 1 
 
Hej Research Institute Karachi University
 patent
silverMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2008-2024

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mohammad Iqbal Choudhary

Introduction

Mohammad Iqbal Choudhary is a prominent inventor based in Karachi, Pakistan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of novel compounds for therapeutic applications. With a total of 3 patents, his work focuses on addressing critical health issues, including diabetes and leishmaniasis.

Latest Patents

One of his latest patents is titled "Role of novel carbazole linked 1, 2, 3- triazole analogs in alleviating methylglyoxal-mediated late diabetic vascular complications." This intervention identifies antiglycating inhibitors from a series of carbazole-linked 1,2,3 triazole derivatives through an in vitro MGO-mediated glycating BSA model. Derivatives 12 and 13 established remarkable antiglycation activity at the receptor level in human monocytes. These compounds were found to be non-toxic and possess the potential to halt AGE-RAGE/ROS-mediated NF-kB-dependent COX-2 and its proinflammatory product, PGE2, production in monocytes. Therefore, carbazole-linked 1,2,3 triazole derivatives provide treatment modalities to delay or prevent the onset of late diabetic micro- and macro-vascular complications in diabetic patients. Another significant patent involves formulations against cutaneous leishmaniasis, detailing the treatment of leishmaniasis in animals and humans using the methanolic extract of petrolatum.

Career Highlights

Choudhary has worked at the Hej Research Institute at Karachi University, where he has contributed to various research projects. His innovative approaches and dedication to research have positioned him as a key figure in his field.

Collaborations

He has collaborated with notable colleagues, including Attaur Rahman and Farzana Shaheen, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Mohammad Iqbal Choudhary's contributions to medicinal chemistry and his innovative patents reflect his commitment to improving health outcomes. His work continues to inspire advancements in therapeutic solutions for critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…